US EditionPublished • loading... • Updated
Amgen joins Trump's DTC push, will offer Repatha at 60% list price discount
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amgen joins Trump's DTC push, will offer Repatha at 60% list price discount
Amgen became the latest drugmaker to unveil a direct-to-consumer offering in response to President Donald Trump’s drug pricing push, announcing Monday that it will sell its cardiovascular medication Repatha for a nearly 60% discount off ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
